There’s Still Time to Buy Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) Stock

In yesterday’s Wall Street session, Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) shares traded at $0.68, up 12.77% from the previous session. 3 analysts cover Aeglea BioTherapeutics Inc. (NASDAQ:AGLE), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $6.00 and a […]

Do futuristic bulls still own Aeglea BioTherapeutics Inc. [AGLE] stock?

Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) shares traded -6.22% lower at $0.43 on Wall Street last session. In accordance with the data, 3 analysts cover Aeglea BioTherapeutics Inc. (NASDAQ:AGLE). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $6.00 and a low of $0.35, […]